Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism

  • Xin Zheng ,

    Contributed equally to this work with: Xin Zheng, Natalia B. Rumie Vittar, Xiaohong Gai

    Affiliations Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Natalia B. Rumie Vittar ,

    Contributed equally to this work with: Xin Zheng, Natalia B. Rumie Vittar, Xiaohong Gai

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Xiaohong Gai ,

    Contributed equally to this work with: Xin Zheng, Natalia B. Rumie Vittar, Xiaohong Gai

    Affiliations Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Maite G. Fernandez-Barrena,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Catherine D. Moser,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Chunling Hu,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Luciana L. Almada,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Angela L. McCleary-Wheeler,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Sherine F. Elsawa,

    Affiliations Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Biological Sciences, Northern Illinois University, DeKalb, Illinois, United States of America

  • Anne M. Vrabel,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Abdirashid M. Shire,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Andrea Comba,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  • Snorri S. Thorgeirsson,

    Affiliation Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  • Youngsoo Kim,

    Affiliation Isis Pharmaceuticals Inc., Carlsbad, California, United States of America

  • Qingguang Liu,

    Affiliation Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

  • Martin E. Fernandez-Zapico,

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  •  [ ... ],
  • Lewis R. Roberts

    roberts.lewis@mayo.edu

    Affiliations Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.